# The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)

> **NCT05371366** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 128 (estimated)

## Conditions studied

- Atrial Septal Defect

## Interventions

- **DEVICE:** ASD closure with the novel occluder (ReAces)
- **DEVICE:** ASD closure with normal occluder

## Key facts

- **NCT ID:** NCT05371366
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-22
- **Primary completion:** 2023-04-22
- **Final completion:** 2023-04-22
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2022-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371366, "The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05371366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*